Results 181 to 190 of about 3,748,422 (364)

Extent of Utilization of Cloud Computing Resources by Students of Computer Science Education Department in Enugu State Universities, Nigeria [PDF]

open access: gold, 2020
Eze Blessing Ngozi   +4 more
openalex   +1 more source

Does provable absence of barren plateaus imply classical simulability? [PDF]

open access: yesNat Commun
Cerezo M   +11 more
europepmc   +1 more source

Math/CompSci Newsletter, Fall 2008 [PDF]

open access: yes, 2008
Department of Mathematics and Computer Science, Bridgewater State College
core   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

Bytes of π, Fall 2009 [PDF]

open access: yes, 2009
Department of Mathematics and Computer Science, Bridgewater State College
core   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

open access: yesMolecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song   +11 more
wiley   +1 more source

Bytes of π, Spring 2010 [PDF]

open access: yes, 2010
Department of Mathematics and Computer Science, Bridgewater State College
core   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy